Open AccessLocally advanced cervical cancer – neoadjuvant chemotherapy followed by concurrent chemoradiation and targeted therapy as maintenance: A phase II study
Author(s) -
Rony Benson,
Sushmita Pathy,
Lalit Kumar,
Sandeep Mathur,
Vatsla Dadhwal,
Bidhu Kalyan Mohanti
Publication year - 2019
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_39_18
Subject(s) - medicine , gefitinib , oncology , cervical cancer , carboplatin , chemoradiotherapy , chemotherapy , neoadjuvant therapy , maintenance therapy , radiation therapy , epidermal growth factor receptor , cancer , cisplatin , breast cancer
The survival in locally advanced cervical cancer remains low. We evaluated the role of neoadjuvant chemotherapy (NACT), chemoradiotherapy (CRT), followed by gefitinib maintenance in locally advanced cervical cancer.